These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 431481)

  • 1. [Substitution and protective therapy with blood components].
    Dietzfelbinger H; Woitinas F
    Med Klin; 1979 May; 74(18):680-5. PubMed ID: 431481
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion support for leukaemia and oncology patients.
    Mayer K
    Clin Haematol; 1984 Feb; 13(1):93-8. PubMed ID: 6373084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential therapy with cellular blood components in internal medicine].
    Hoppe I
    Med Klin; 1979 May; 74(18):695-700. PubMed ID: 431482
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood: use and abuse of whole blood and fractions.
    Saidi P
    Clin Ther; 1983; 5(4):327-34. PubMed ID: 6871916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Principal clinical indications for direct transfusion therapy].
    Silvestri G; Radicioni P
    Minerva Med; 1977 Sep; 68(42):2983-92. PubMed ID: 909645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New aspects of therapy with blood and blood components].
    Frick U; Frick G
    Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective transfusion of blood components.
    McCredie KB
    Int Adv Surg Oncol; 1981; 4():145-71. PubMed ID: 7019094
    [No Abstract]   [Full Text] [Related]  

  • 8. [Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia].
    Rasche H
    Beitr Infusionther Klin Ernahr; 1986; 15():179-86. PubMed ID: 3530242
    [No Abstract]   [Full Text] [Related]  

  • 9. Current transfusion practices.
    Pierce LE; Beall CL
    Am Fam Physician; 1975 Mar; 11(3):129-36. PubMed ID: 1114933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the management of acute nonlymphocytic leukemia.
    Wiernik PH
    Arch Intern Med; 1976 Dec; 136(12):1399-403. PubMed ID: 826228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)].
    Höcker P; Pittermann E; Mann M; Krasa E
    Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy using blood components. Prerequisites, indications and clinical use].
    Glück D; Kubanek B; Ahnefeld FW
    Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversial and changing trends in blood transfusion.
    Hollán SR
    Vox Sang; 1981 May; 40(5):309-16. PubMed ID: 7245716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion therapy in pediatric oncology.
    Greenbaum BH; Herman JH
    Pediatr Ann; 1988 Nov; 17(11):687-93. PubMed ID: 3070469
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood component therapy in neonatal medicine.
    Lenes BA; Sacher RA
    Clin Lab Med; 1981 Jun; 1(2):285-309. PubMed ID: 6809397
    [No Abstract]   [Full Text] [Related]  

  • 16. Supportive care: twenty years of progress.
    Jaffe N; Buell DN
    Pediatr Ann; 1978 Jul; 7(7):508-11. PubMed ID: 97615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stability of blood cell preparations for malignant blood diseases].
    Kekomäki R
    Duodecim; 1989; 105(11):1138-47. PubMed ID: 2666096
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of blood and blood components for feline and canine patients.
    Killingsworth CR
    J Am Vet Med Assoc; 1984 Dec; 185(11):1452-4. PubMed ID: 6511618
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on blood component transfusion with continuous blood cell separator (IBM 2997). Part 2: methods of granulocyte and platelet harvesting and efficacies of the component transfusion].
    Toki H; Ishikawa M
    Rinsho Ketsueki; 1982 Apr; 23(4):441-8. PubMed ID: 7131790
    [No Abstract]   [Full Text] [Related]  

  • 20. The present status of blood component therapy in the United States.
    Schiffer CA
    Rinsho Ketsueki; 1978 Oct; 19(10):1467-73. PubMed ID: 368374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.